Locally Advanced or Metastatic ER+ HER2- Breast Cancer

1

Review clinical trials related to Locally Advanced or Metastatic ER+ HER2- Breast Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study of PF-07248144 in Advanced or Metastatic Solid Tumors

This is an open-label, multi center study to evaluate safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of PF-07248144 and early signs of clinical efficacy of PF-07248144 as a single agent and in combination with other agents

Participants needed: 320
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: PfizerUpdated: Apr 16, 2026Locations: 44
Eligibility criteria

Disease Characteristics - Breast, Prostate, and Lung Cancer [+15]

Unmanageable ascites (limited medical treatment to control ascites is permitted,... [+8]